MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,176
Unique beneficiaries
—
Total services
10,339
Distinct HCPCS
33
Medicare payment
$268K
Peer benchmark
Total Medicare services vs. 627 Endocrinology providers in NY — top quintile (cohort median 837).
PRESCRIBING · PART D · 2024
Total Rx claims
3,409
Beneficiaries
—
Total drug cost
$1.2M
Distinct drugs
55
Brand share
43.8%
Top prescribed drugs
Levothyroxine Sodium475 claims
Metformin Hcl281 claims
Levothyroxine Sodium205 claims
Metformin Hcl199 claims
Tirzepatide174 claims
QUALITY · MIPS · 2024
Final MIPS score
94.2
Quality
87.3
Cost
81.0
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.81%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$1K
Payment records
55
By payment type
Food and Beverage$1K
Top paying entities
Food and Beverage$1K
REFERRAL NETWORK
Where Janna Cohen-Lehman's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 7 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ | 27 | 65 |
| GOOD SAMARITAN HOSPITAL OF SUFFERN | 24 | 60 |
| Bioreference Health, Llc Clinical Laboratory · Elmwood Park, NJ | 22 | 69 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| Bioreference Health, Llc Clinical Laboratory · Elmwood Park, NJ | 64 | 250 |
| Quest Diagnostics Incorporated Clinical Laboratory · Clifton, NJ | 37 | 140 |
| GOOD SAMARITAN HOSPITAL OF SUFFERN | 34 | 102 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ | 24 | 78 |
| Valeria Silberman Internal Medicine · Suffern, NY | 21 | 92 |
| Amala Chirumamilla Cardiology · Suffern, NY | 13 | 27 |
| SHIEL HOLDINGS LLC | 12 | 41 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE